Encompass Health (US:EHC) Financial Modeling Prepยท2025-10-05 22:00Core Viewpoint - Encompass Health Corporation is facing scrutiny due to allegations of misleading business information, leading to a potential class action lawsuit by The Rosen Law Firm on behalf of shareholders [1][2][6] Group 1: Legal and Regulatory Issues - The Rosen Law Firm is investigating potential securities claims against Encompass Health following allegations of misleading business information [1][6] - A New York Times article reported serious incidents of patient harm and below-average safety performance at some of Encompass Health's rehab hospitals, resulting in a 10.3% drop in stock price on the day of publication [1] Group 2: Market Performance and Analyst Opinions - UBS upgraded Encompass Health's stock to a "Buy" on October 2, 2025, raising the price target from $140 to $150, indicating confidence in the company's future performance despite recent controversies [3][6] - Encompass Health's current stock price is $123.23, reflecting a slight decrease of 0.32, or -0.259% [4][6] - The stock has shown volatility over the past year, with a high of $127.86 and a low of $87.85 [4] Group 3: Financial Metrics - Encompass Health's market capitalization is approximately $12.41 billion, with a trading volume of 1,017,291 shares on the NYSE, indicating a significant market presence [5][6]